Osmotica Pharmaceuticals plc
Osmotica Pharmaceuticals plc operates in various business sectors.
Osmotica Pharmaceuticals plc (O1P) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: -0.739x
Based on the latest financial reports, Osmotica Pharmaceuticals plc (O1P) has a cash flow conversion efficiency ratio of -0.739x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-12.06 Million) by net assets (€16.33 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Osmotica Pharmaceuticals plc - Cash Flow Conversion Efficiency Trend (2018–2022)
This chart illustrates how Osmotica Pharmaceuticals plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Osmotica Pharmaceuticals plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Osmotica Pharmaceuticals plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MULTIPOLAR -A- (MLQ2.SG)
STU:MLQ2
|
N/A |
|
SMB Leasing PLC
CM:SEMBN0000
|
N/A |
|
DEAP CAPITAL MANAGEMENT AND TRUST PLC
XNSA:DEAPCAP
|
N/A |
|
Silkbank Ltd
KAR:SILK
|
-1.649x |
|
Cabo Verde Capital Inc
PINK:CAPV
|
0.000x |
|
Sumo Resources PLC
PA:MLSUM
|
N/A |
|
Agri-Dynamics Inc
PINK:AGDY
|
0.050x |
|
Cann American Corp
PINK:CNNA
|
-1.263x |
Annual Cash Flow Conversion Efficiency for Osmotica Pharmaceuticals plc (2018–2022)
The table below shows the annual cash flow conversion efficiency of Osmotica Pharmaceuticals plc from 2018 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | €51.09 Million | €-37.81 Million | -0.740x | -3.75% |
| 2021-12-31 | €76.73 Million | €-54.73 Million | -0.713x | -480.59% |
| 2020-12-31 | €93.86 Million | €17.59 Million | 0.187x | -35.96% |
| 2019-12-31 | €114.71 Million | €33.57 Million | 0.293x | +200.96% |
| 2018-12-31 | €386.27 Million | €37.56 Million | 0.097x | -- |